10:30 AM EST - Fennec Pharmaceuticals Inc. : Reported its financial results for the fiscal quarter ended September 30. Net loss for the three months was $8.1 million ($0.31 per share), compared to $4.2 million ($0.16 per share) for the same period in 2021. Fennec Pharmaceuticals Inc.
shares T.FRX are trading un at $10.85.
